# Lisdexamfetamine dimesylate

NDC: 0480-3564
Generic name: Lisdexamfetamine dimesylate
Labeler / Manufacturer: Teva Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20241217

FDA application: ANDA202802

## Active ingredients

- LISDEXAMFETAMINE DIMESYLATE: 70 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0480-3564"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0480-3564
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c32b5dce-2de4-4db0-a4ba-d2ce3b0a32fc